Beta Bionics (BBNX) Revenue & Revenue Breakdown
Beta Bionics Revenue Highlights
Latest Revenue (Y)
$65.12M
Latest Revenue (Q)
$27.25M
Beta Bionics Revenue by Period
Beta Bionics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $65.12M | 442.93% |
| 2023-12-31 | $11.99M | 6601.12% |
| 2022-12-31 | $179.00K | - |
Beta Bionics generated $65.12M in revenue during NA 2024, up 442.93% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Beta Bionics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $27.25M | 17.28% |
| 2025-06-30 | $23.24M | 31.74% |
| 2025-03-31 | $17.64M | -13.70% |
| 2024-12-31 | $20.44M | 22.36% |
| 2024-09-30 | $16.70M | 11.03% |
| 2024-06-30 | $15.05M | 16.34% |
| 2024-03-31 | $12.93M | 54.89% |
| 2023-12-31 | $8.35M | 169.96% |
| 2023-09-30 | $3.09M | - |
Beta Bionics generated $27.25M in revenue during Q3 2025, up 17.28% compared to the previous quarter, and up 181.13% compared to the same period a year ago.
Beta Bionics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AHCO | AdaptHealth | $3.26B | $820.31M |
| DVAX | Dynavax | $277.25M | $95.44M |
| BBNX | Beta Bionics | $65.12M | $27.25M |
| IMTX | Immatics | $54.00M | $30.45M |
| KMTS | KESTRA MEDICAL | $27.81M | $22.57M |
| PGEN | Precigen | $3.92M | $856.00K |
| STAA | STAAR Surgical | $313.90K | $44.32B |
| PLSE | Pulse Biosciences | - | - |
| TRML | Tourmaline Bio | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| ORIC | ORIC Pharmaceuticals | - | - |